RY 170.3 -0.8096% SHOP 145.34 -0.4452% TD 78.23 0.3206% ENB 59.82 -0.2168% BN 78.84 -0.5801% TRI 224.58 0.0445% CNQ 47.21 0.3614% CP 102.88 -0.1843% CNR 149.43 0.2348% BMO 131.48 0.0533% BNS 78.71 0.421% CSU 4503.0698 1.5097% CM 90.72 0.9683% MFC 45.03 -1.0547% ATD 77.2 -0.5026% NGT 60.11 -0.2489% TRP 68.79 -1.1638% SU 57.1 -0.1923% WCN 260.8 -0.401% L 177.26 1.1758%

Jamieson Wellness Inc

Consumer Defensive CA JWEL

35.63CAD
0.38(1.08%)

Last update at 2024-11-20T21:00:00Z

Day Range

34.9835.69
LowHigh

52 Week Range

23.6535.90
LowHigh

Fundamentals

  • Previous Close 35.25
  • Market Cap1492.63M
  • Volume25388
  • P/E Ratio39.30
  • Dividend Yield2.36%
  • EBITDA100.85M
  • Revenue TTM709.36M
  • Revenue Per Share TTM17.04
  • Gross Profit TTM 198.34M
  • Diluted EPS TTM0.91

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 70.50M 70.47M 57.05M 42.30M 37.25M
Minority interest - - - - -
Net income 52.81M 52.08M 41.60M 31.66M 26.67M
Selling general administrative 115.15M 86.41M 81.18M 74.28M 66.29M
Selling and marketing expenses - - - - -
Gross profit 198.34M 162.44M 144.76M 129.73M 115.42M
Reconciled depreciation 17.25M 14.27M 12.21M 10.92M 9.05M
Ebit 83.19M 76.03M 63.57M 55.45M 44.80M
Ebitda 100.44M 90.30M 75.76M 61.92M 53.84M
Depreciation and amortization 17.25M 14.27M 12.19M 6.47M 9.05M
Non operating income net other - - - - -
Operating income 83.19M 76.03M 63.57M 55.45M 50.09M
Other operating expenses 464.18M 375.00M 340.09M 289.53M 270.65M
Interest expense 12.42M 5.66M 6.04M 8.29M 7.55M
Tax provision 17.70M 18.38M 15.45M 10.65M 10.58M
Interest income 12.69M 5.57M 6.50M 9.78M 9.61M
Net interest income -12.41700M -5.65700M -6.04200M -10.81400M -9.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 17.70M 18.38M 15.45M 10.65M 10.58M
Total revenue 547.37M 451.03M 403.66M 344.98M 319.78M
Total operating expenses 115.15M 86.41M 81.18M 74.28M 66.29M
Cost of revenue 349.03M 288.59M 258.90M 215.25M 204.36M
Total other income expense net -12.68600M -5.56500M -6.52400M -13.14500M -12.83900M
Discontinued operations - - - - -
Net income from continuing ops 52.81M 52.08M 41.60M 31.66M 26.67M
Net income applicable to common shares 52.81M 52.08M 41.60M 31.66M 26.67M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1143.57M 1107.26M 652.48M 609.34M 561.77M
Intangible assets 366.52M 367.20M 192.68M 196.16M 198.19M
Earning assets - - - - -
Other current assets 9.04M 10.88M 7.18M 2.39M 1.89M
Total liab 662.38M 675.67M 310.45M 316.94M 302.61M
Total stockholder equity 438.93M 431.59M 342.02M 292.40M 259.17M
Deferred long term liab - - - - -
Other current liab 7.55M 26.04M 25.70M 32.48M 17.30M
Common stock 312.59M 307.20M 268.21M 255.79M 243.22M
Capital stock 312.59M 307.20M 268.21M 255.79M 243.22M
Retained earnings 80.65M 85.48M 59.00M 29.02M 6.06M
Other liab - 95.63M 56.84M 55.02M 55.03M
Good will 274.41M 272.92M 122.97M 122.97M 122.97M
Other assets - 3.03M 2.70M 2.26M 2.27M
Cash 36.86M 26.24M 6.78M 1.17M 0.20M
Cash and equivalents - - - - -
Total current liabilities 145.33M 154.81M 83.62M 91.01M 73.34M
Current deferred revenue 53.78M - - - -
Net debt 426.12M 373.76M 142.35M 147.89M 164.57M
Short term debt 7.55M 0.00000M 0.00000M 14.62M 0.00000M
Short long term debt - - - - -
Short long term debt total 462.99M 400.00M 149.12M 149.06M 164.77M
Other stockholder equity 33.79M 17.11M 14.79M 12.99M 10.73M
Property plant equipment - 111.71M 96.98M 83.80M 64.91M
Total current assets 392.86M 352.40M 237.15M 204.15M 173.43M
Long term investments - - - - -
Net tangible assets - -208.53000M 26.37M -26.73100M -61.99600M
Short term investments 3.29M - - - -
Net receivables 164.50M 160.80M 104.19M 97.95M 89.39M
Long term debt 325.00M 400.00M 149.12M 149.06M 164.77M
Inventory 182.46M 154.49M 119.01M 102.64M 81.95M
Accounts payable 76.46M 128.77M 57.92M 58.53M 56.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 11.89M 21.79M 0.02M -5.40200M -0.84400M
Additional paid in capital - - - - -
Common stock total equity - - - 255.79M 243.22M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.88M - - - 388.34M
Deferred long term asset charges - - - - -
Non current assets total 750.71M 754.86M 415.33M 405.19M 388.34M
Capital lease obligations - - - - -
Long term debt total - 461.93M 170.00M 170.91M 174.24M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -256.53000M -22.28400M -13.16900M -9.49800M -11.53700M
Change to liabilities 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities -256.53000M -22.28400M -13.16900M -9.49800M -11.53700M
Net borrowings 247.54M -3.14000M -18.07900M -6.08300M 1.25M
Total cash from financing activities 225.41M -16.51200M -26.45900M -19.14500M -8.65600M
Change to operating activities -27.01200M -27.32600M -20.20400M -34.49900M -5.17000M
Net income 52.81M 52.08M 41.60M 31.66M 26.67M
Change in cash 19.46M 5.61M 0.97M -12.24700M 7.61M
Begin period cash flow 6.78M 1.17M 0.20M 12.45M 4.83M
End period cash flow 26.24M 6.78M 1.17M 0.20M 12.45M
Total cash from operating activities 50.59M 44.41M 40.60M 16.40M 27.80M
Issuance of capital stock - - - - 0.00000M
Depreciation 17.25M 14.27M 12.21M 10.92M 9.05M
Other cashflows from investing activities -242.59700M -0.78600M -1.91800M -0.47100M -0.60200M
Dividends paid 26.32M 22.11M 18.64M 14.69M 12.94M
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock 4.19M 8.73M 10.26M 1.62M 3.03M
Other cashflows from financing activities 343.58M 81.62M 70.55M 48.85M 40.94M
Change to netincome 7.54M 5.38M 6.99M 5.30M -4.19700M
Capital expenditures 14.57M 22.28M 13.17M 9.50M 11.54M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -27.01200M -27.32600M -20.20400M -34.49900M -5.17000M
Stock based compensation 4.76M 5.48M 4.57M 3.88M 3.07M
Other non cash items 1.12M 0.38M 0.48M 3.33M -6.00700M
Free cash flow 36.02M 22.12M 27.43M 6.90M 16.27M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
JWEL
Jamieson Wellness Inc
0.38 1.08% 35.63 39.30 17.45 2.10 3.36 2.51 18.26
SAP
Saputo Inc
-0.05 0.19% 26.00 42.40 15.43 0.63 1.53 0.82 13.35
PBH
Premium Brands Holdings Corporation
-0.01 0.01% 80.34 34.84 14.31 0.54 1.96 0.98 12.08
MFI
Maple Leaf Foods Inc.
-0.02 0.09% 22.62 252.22 15.77 0.58 1.76 0.97 10.14
HLF
High Liner Foods Incorporated
-0.25 1.67% 14.74 6.88 6.36 0.41 0.73 0.52 5.03

Reports Covered

Stock Research & News

Profile

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. The company offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. It also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women, including hormone imbalances, nutrient deficiencies, and sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. The company offers its contract manufacturing services under the Nurticorp brand. It sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

Jamieson Wellness Inc

TD Bank Tower, Toronto, ON, Canada, M5K 1E6

Key Executives

Name Title Year Born
Mr. Michael Pilato Pres, CEO & Director 1975
Mr. Christopher Snowden CFO & Corp. Sec. NA
Ms. Regan Stewart Chief Operations & People Officer NA
Mr. John Doherty Chief Science & Innovation Officer 1973
Mr. Don Bird Exec. VP of USA & Global Strategic Partners 1964
Ruth Winker Corp. Communications Director NA
Mr. Eric Bentz Sr. VP of Global Marketing & MD of China NA
Mr. Paul Galbraith Sr. VP & MD of Canada NA
Mr. Joel Scales Exec. VP of Jamieson Worldwide, Global Strategy & E-Commerce NA
Mr. Michael Pilato President, CEO & Director 1975

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.